Cargando…
Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor
Secondary glioblastoma is a rare brain tumor characterized by a mutation in isocitrate dehydrogenase, which is reported to lead to epigenetic modification. Patients with secondary glioblastoma experience poor survival and quality-of-life outcomes due to the disease’s aggressiveness and a lack of tar...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104214/ https://www.ncbi.nlm.nih.gov/pubmed/32257248 http://dx.doi.org/10.1093/omcr/omaa006 |